BURGESS DANIEL D 4
4 · Arbutus Biopharma Corp · Filed May 24, 2024
Insider Transaction Report
Form 4
BURGESS DANIEL D
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-23+67,000→ 67,000 totalExercise: $3.28From: 2024-05-23Exp: 2034-05-23→ Common Shares (67,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
- [F2]The option is fully vested and exercisable as of the date of the grant.